Elevance Health, Inc.
ELVHealthcareNASDAQHealthcare Plans
Scan Results
Daily timeframeElevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The $88.37B market capitalization puts ELV squarely in large-cap range for its industry. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Market Cap
$88.37B
Beta
0.70
P/E (TTM)
18.02
P/E (Fwd)
13.76
EPS (TTM)
$22.61
EPS (Fwd)
$29.61
ROE
11.1%
ROA
3.8%
Cash
$37.51B
Total Debt
$31.04B
Free CF
$4.31B
52W Change
32.3%
Annual Financials
Cash vs Debt
Where ELV stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ELV finished 12.56% above its 150-day moving average ($360.56) and 13.83% above its 200-day moving average ($356.54). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ELV overbought or oversold?
At the September 3, 2026 close, ELV's RSI(14) was 56.4, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Elevance Health, Inc. holds $37.51B in cash against $31.04B in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $4.31B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 11.1%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.8% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $156.59B (2022) to $199.12B (2025), reflecting a 27% increase over the period.
ELV's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing ELV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.